ArticleProceedings of the National Academy of Sciences of the United States of America2020
Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
Xiaoling Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.